Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 February 2019
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Sophie today toured Melanoma Institute Australia’s research and treatment centre in Sydney, where she met a young family devastated by melanoma. She spent time with little Madi who was only three-years-old when she lost her dad Peter to melanoma.
MIA CEO Matthew Browne says the organisation is thrilled to have Sophie onboard as the Queensland-based media personality is relatable to 15-39 year olds, the age bracket in which melanoma is the most common cancer.
"Sophie, like many Australians, has grown up living an outdoor, active lifestyle which all too often can have dire consequences,” Matthew said. “Many people don’t realise how common melanoma is, with more than 14,000 Australians expected to be diagnosed with the disease this year. By having Sophie onboard we will better be able to reach young Australians with sun-safety and skin awareness messages."
After having a close friend diagnosed with melanoma, and then watching her dad battle with skin cancer, Sophie was shocked to learn that melanoma is the most common cancer affecting 15 to 39 year old Australians.
I love going to the beach as much as the next Australian, but now seeing just how prevalent melanoma is among young people, it has prompted me to spread the sun safety message so no one has to go through this devastating diagnosis, Sophie said.
Sophie will use her public profile as one of Australia’s most loved television and radio personalities to warn other young Aussies of the risk of sun exposure and the need to be vigilant in checking their skin for changes.
"When I first came back to Australia the thing I noticed most was how much time Australians spend in the sun, so I was constantly reminding my family to put on sunscreen. We should all be using sunscreen and checking our skin, in the same way we clean our teeth every day. And if you notice any changes to your skin, you need to get checked professionally ASAP. I know it can be a pain but it could be the difference between life and death. I’ll be nagging all my friends and family to book in to get their initial skin check!"
Sophie has also generously come on board as an Ambassador for Melanoma Institute Australia’s national awareness campaign, Melanoma March, which includes 23 family friendly walks across every state and territory in Australia, as well as the 2000km Jay’s Longest Melanoma March from Adelaide to Sydney. The campaign raises vital funds for melanoma research.
Our goal is zero deaths from melanoma, and whilst recent clinical advances have tripled life expectancy of some advanced melanoma patients, we still have one Australian dying from the disease every five hours,” said Matthew Browne. “It is vital we fund ongoing research so we can save more lives.
"I grew up in sunny Queensland and it’s only through hearing the devastating stories about melanoma that I now realise how deadly the disease can be, and the importance of sun safety, especially among the younger generation,” Sophie said.
Join your local Melanoma March to help raise awareness as well as much-needed funds so that one day no one will have to die from melanoma,” Sophie said.
For more information on how to register for a march near you or donate to Melanoma March, go to www.melanomamarch.org.au
Melanoma March 2019 is an initiative of Melanoma Institute Australia. In South Australia, we work alongside Australian Melanoma Research Foundation; in Western Australia, we work with melanomaWA; and in Victoria, we work with the Skin & Cancer Foundation Inc.
Melanoma March 2019 Principal Partner is Ricky, and Supporting Partners include Sun Sense, Skin & Cancer Foundation Inc., Toyota and Kensington Parry.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.